2010 Sales Reps Visits and Product Details

Market Insight Report from

Find Out Which Pharma Company Increased its Sales Force by 242% in 2010

Click to download now!

Over 90% of details to general practitioners lasted 10 minutes or less in 2010, according to the 2010 Sales Rep Visits and Product Detailing report by Cegedim Strategic Data. This pivotal report contains insights such as the duration of sales visits, sample drop mix, top 10 detailed products, and the size of pharma sales forces in 2010. Use this valuable report to discover trends, learn what your competitors are doing with their sales force, and understand the current state of prescriber behavior.

Almost half of details to general practitioners were under 5 minutes

 

Download this complimentary report today

The report highlights:

  • The 30 pharmaceutical companies with the biggest change in sales force size

  • Top 10 most detailed pharmaceutical products in the U.S.

  • Changes in the duration of sales visits since 2006

  • Trends in sample and brochure distribution

  • Factors surrounding the changing landscape of pharma detailing

Linkedin Facebook Twitter Youtube myspace SK&A Mobile Alerts
2601 Main Street, Suite 650, Irvine, CA 92614, Phone: (800) 752-5478, Fax:(949) 476-2168, E-mail: skasales@skainfo.com

Blog Us   Privacy Policy

 



Advertise
For details on how to advertise in MM&M KOL White Paper, please email Doreen Gatest.

Subscribe
If you were sent this by a colleague and wish to subscribe to the MM&M KOL White Paper, please click here.

You are subscribed as: %%EMAIL%%

Unsubscribe
To unsubscribe from the MM&M KOL White Paper click here.
To manage your entire MM&M profile login to your account.

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Haymarket Media Inc
114 West 26th St 4th floor
New York, NY 10001

© 2013 Haymarket Media Inc.